Respuesta de la empresa

Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Gilead Sciences no ha respondido a

Prices of AIDS medicines in developing countries continue to be a concern

Historia 28 jun 2005

Línea del tiempo

Prices of AIDS medicines in developing countries continue to be a concern

Fecha:

28 jun 2005

Tipo de contenido:

Artículo

Idiomas disponibles: English
Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Fecha:

28 jun 2005

Tipo de contenido:

Respuesta de la empresa

Idiomas disponibles: English

Ver la historia completa